FindTrial
Sign In

Fecal Microbiota Transplantation for non-alcoholic fatty liver disease Through Colonic Transendoscopic Enteral Tubing

Fecal Microbiota Transplantation for non-alcoholic fatty liver disease Through Colonic Transendoscopic Enteral Tubing

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017000
Enrollment
Unknown
Registered
2018-07-07
Start date
2018-08-01
Completion date
Unknown
Last updated
2018-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-alcoholic fatty liver disease, NAFLD

Interventions

treatment group:FMT
control group:Normal saline

Sponsors

Guangzhou First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 ~ 65 years old; 2. According to the guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease in China (2018 Edition), it is diagnosed as NAFL or NASH; 3. Contraindications of FMT without treatment; 4. Able and willing to sign informed consent.

Exclusion criteria

Exclusion criteria: 1. viral hepatitis, alcoholic liver disease, autoimmune liver disease, toxic liver damage and drug-induced liver injury. 2. End-stage liver disease, such as liver cirrhosis and liver cancer; 3. Hepatolenticular degeneration (Wilson's's disease) and other metabolic and hereditary liver diseases; 4. Women of pregnancy or lactation; 5. Contraindications for treatment with FMT.

Design outcomes

Primary

MeasureTime frame
Histology of liver;—

Secondary

MeasureTime frame
Intestinal microflora diversity;liver function;—

Countries

China

Contacts

Public ContactHUITING CHEN

Guangzhou First People's Hospital

460115003@qq.com+86 13926055294

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026